In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine ...

China restated its case that Covid-19 may have originated in the United States in a white paper on its pandemic response ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

China is blaming the United States for the origin of COVID-19, accusing Washington of "evading responsibility" for the virus ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The Chinese accusations come after the White House revamped its COVID-19 information earlier this month to push out the assertion that COVID-19 leaked out of a lab in the Wuhan Institute of ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Kennedy has focused his healthcare crusade on his contention that American healthcare prioritizes treating chronic illnesses ...

BEIJING (Reuters) -China released a white paper on COVID-19 prevention, control and origins tracing on Wednesday, the ...

Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.